Eskola O - Search Results

1

Mortality in Parkinson's disease is not associated with the severity of early dopaminergic defect.

Järvelä JT, Rinne JO, Eskola O, Kaasinen V. Järvelä JT, et al. Among authors: eskola o. Parkinsonism Relat Disord. 2014 Aug;20(8):894-7. doi: 10.1016/j.parkreldis.2014.05.010. Epub 2014 Jun 2. Parkinsonism Relat Disord. 2014. PMID: 24928032

2

Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.

Nurmi E, Bergman J, Eskola O, Solin O, Hinkka SM, Sonninen P, Rinne JO. Nurmi E, et al. Among authors: eskola o. J Cereb Blood Flow Metab. 2000 Nov;20(11):1604-9. doi: 10.1097/00004647-200011000-00010. J Cereb Blood Flow Metab. 2000. PMID: 11083235 Clinical Trial.

3

Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging.

Ruottinen HM, Niinivirta M, Bergman J, Oikonen V, Solin O, Eskola O, Eronen E, Sonninen P, Rinne UK. Ruottinen HM, et al. Among authors: eskola o. Synapse. 2001 Apr;40(1):19-26. doi: 10.1002/1098-2396(200104)40:1<19::AID-SYN1022>3.0.CO;2-7. Synapse. 2001. PMID: 11170218

4

[(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.

Rinne OJ, Nurmi E, Ruottinen HM, Bergman J, Eskola O, Solin O. Rinne OJ, et al. Among authors: eskola o. Synapse. 2001 Jun 1;40(3):193-200. doi: 10.1002/syn.1042. Synapse. 2001. PMID: 11304757

5

Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex.

Kaasinen V, Nurmi E, Brück A, Eskola O, Bergman J, Solin O, Rinne JO. Kaasinen V, et al. Among authors: eskola o. Brain. 2001 Jun;124(Pt 6):1125-30. doi: 10.1093/brain/124.6.1125. Brain. 2001. PMID: 11353728

6

Personality traits and brain dopaminergic function in Parkinson's disease.

Kaasinen V, Nurmi E, Bergman J, Eskola O, Solin O, Sonninen P, Rinne JO. Kaasinen V, et al. Among authors: eskola o. Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13272-7. doi: 10.1073/pnas.231313198. Epub 2001 Oct 30. Proc Natl Acad Sci U S A. 2001. PMID: 11687621 Free PMC article.

7

Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.

Nurmi E, Bergman J, Eskola O, Solin O, Vahlberg T, Sonninen P, Rinne JO. Nurmi E, et al. Among authors: eskola o. Synapse. 2003 Jun 1;48(3):109-15. doi: 10.1002/syn.10192. Synapse. 2003. PMID: 12645035

8

Altered dopamine D2 receptor binding in atypical facial pain.

Hagelberg N, Forssell H, Aalto S, Rinne JO, Scheinin H, Taiminen T, Någren K, Eskola O, Jääskeläinen SK. Hagelberg N, et al. Among authors: eskola o. Pain. 2003 Nov;106(1-2):43-8. doi: 10.1016/s0304-3959(03)00275-6. Pain. 2003. PMID: 14581109

9

Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.

Forsback S, Niemi R, Marjamäki P, Eskola O, Bergman J, Grönroos T, Haaparanta M, Haapalinna A, Rinne J, Solin O. Forsback S, et al. Among authors: eskola o. Synapse. 2004 Feb;51(2):119-27. doi: 10.1002/syn.10293. Synapse. 2004. PMID: 14618679

10

Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.

Jokinen P, Helenius H, Rauhala E, Brück A, Eskola O, Rinne JO. Jokinen P, et al. Among authors: eskola o. J Nucl Med. 2009 Jun;50(6):893-9. doi: 10.2967/jnumed.108.061572. Epub 2009 May 14. J Nucl Med. 2009. PMID: 19443601 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page